Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

about

Predictors of acute kidney injury after paraquat intoxication.

P2860

Q41612773-7227BB0C-6C3F-430B-B02D-50F039160526

P2860

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

Item

http://www.wikidata.org/entity/Q36400103

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Terlipressin and albumin for t ...... infection affect the response?

@ast

Terlipressin and albumin for t ...... infection affect the response?

@en

type

Item

label

Terlipressin and albumin for t ...... infection affect the response?

@ast

Terlipressin and albumin for t ...... infection affect the response?

@en

prefLabel

Terlipressin and albumin for t ...... infection affect the response?

@ast

Terlipressin and albumin for t ...... infection affect the response?

@en

P1476

Terlipressin and albumin for t ...... infection affect the response?

@en

P2093

Emre Yıldırım

http://www.w3.org/2001/XMLSchema#string

Enver Akbaş

http://www.w3.org/2001/XMLSchema#string

Haldun Selçuk

http://www.w3.org/2001/XMLSchema#string

Murat Korkmaz

http://www.w3.org/2001/XMLSchema#string

Reskan Altun

http://www.w3.org/2001/XMLSchema#string

Serkan Öcal

http://www.w3.org/2001/XMLSchema#string

P2860

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.

Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.

Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?

Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.

Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.

Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.

A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome

Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.

P2888

s40064-015-1625-z

P304

806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40064-015-1625-Z

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288073686

http://www.w3.org/2001/XMLSchema#string

P6179

1009004472

http://www.w3.org/2001/XMLSchema#string

P698

26722626

http://www.w3.org/2001/XMLSchema#string

P932

4689717

http://www.w3.org/2001/XMLSchema#string

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

about

P2860

P2860

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932